Independent Director · Fulcrum Therapeutics, Inc. (FULC)

Chair, Compensation Committee

Rachel King director compensation at Fulcrum Therapeutics: $266K

Fiscal year 2025 director compensation for Rachel King at Fulcrum Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 30, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Rachel King’s full pay file as a PDF — free

More than this page: up to 10 years of Rachel’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Rachel King and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Fulcrum Therapeutics Director Compensation Table · all 2 fiscal years held
In US dollars, as Fulcrum Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$46,359—$219,406—$265,765
FY2024$6,114$0$182,160$0$188,274

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Fulcrum Therapeutics, Inc. DEF 14A filed April 30, 2026, accession 0001193125-26-197196, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Fulcrum Therapeutics, Inc. filed document, accession 0001193125-26-197196. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

Get the Fulcrum Therapeutics Board Governance Report

$265,765 Rachel King, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 30, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Fulcrum Therapeutics pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Compensation (Chair)

The rest of the Fulcrum Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alan EzekowitzIndependent Director$273,047
Alex C. SapirDirector—
Colin HillIndependent Director$264,406
James GeraghtyIndependent Director$274,906
Josh LehrerDirector—
Kate HavilandChair of the Board$300,906
Katina DortonIndependent Director$279,406
Robert J. GouldDirector$269,406
Sonja L. BanksIndependent Director$263,406

The full Fulcrum Therapeutics compensation record

free company brief

This page is one director within Fulcrum Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order FULC

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report